Presented:

NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2019 Earnings Release for February 27, 2020

Read Now

Presented:

NeoGenomics Announces Leadership Appointments

Read Now

Presented:

NeoGenomics Acquires Oncology Division from Human Longevity for $37 Million

Read Now

Presented:

EBV-Positive Primary Large B-Cell Lymphoma: The Role of Immunohistochemistry and XPO1 in the Diagnosis of Mediastinal Lymphomas

Read Now

Presented:

NeoGenomics To Participate In Fireside Chat At Stephens 21st Annual Investment Conference

Read Now

Presented:

NeoGenomics Reports 51% Revenue Growth to $105 Million in the Third Quarter

Read Now

Presented:

NeoGenomics Schedules its Third Quarter Earnings Release for October 29, 2019

Read Now

Presented:

NeoGenomics To Present At 2019 Cantor Global Healthcare Conference

Read Now

Presented:

NeoGenomics to Participate in Two Upcoming September Institutional Investor Conferences

Read Now

Presented:

NeoGenomics Announces Leadership Transition and Reiterates Recently Increased 2019 Financial Guidance

Read Now